Information:
Fel:
ID
23807
Beskrivning
Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum https://clinicaltrials.gov/ct2/show/NCT00077233
Länk
https://clinicaltrials.gov/ct2/show/NCT00077233
Nyckelord
Versioner (2)
- 2012-08-27 2012-08-27 -
- 2017-07-14 2017-07-14 - Martin Dugas
Uppladdad den
14 juli 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Metastatic Colorectal Cancer Fluorouracil Leucovorin Irinotecan Oxaliplatin NCT00077233 CALGB 80203
No Instruction available.
- StudyEvent: CALGB: 80203 DERMATOLOGY SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE (DSQL)
Similar models
No Instruction available.
- StudyEvent: CALGB: 80203 DERMATOLOGY SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE (DSQL)
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Patient Hospital Number
Item
Patient Hospital No.
text
C0421459 (UMLS CUI [1])
Institution/Affiliate
Item
Institution/Affiliate
text
C1301943 (UMLS CUI [1])
Participating Group
Item
Participating Group
text
C2347449 (UMLS CUI [1])
Participating Group Protocol Number
Item
Participating Group Protocol No.
text
C3274381 (UMLS CUI [1,1])
C2347449 (UMLS CUI [1,2])
C2347449 (UMLS CUI [1,2])
Participating Group Patient ID
Item
Participating Group Patient ID
text
C2348585 (UMLS CUI [1])
CALGB Study Number
Item
CALGB Study No.
text
C3274381 (UMLS CUI [1,1])
C1516238 (UMLS CUI [1,2])
C1516238 (UMLS CUI [1,2])
CALGB Patient ID
Item
CALGB Patient ID
text
C2348585 (UMLS CUI [1,1])
C1516238 (UMLS CUI [1,2])
C1516238 (UMLS CUI [1,2])
Data amended
Item
Are data amended
boolean
C1691222 (UMLS CUI [1])
Item Group
Cetuximab Skin Toxicities
C0995188 (UMLS CUI-1)
C1167791 (UMLS CUI-2)
C1167791 (UMLS CUI-2)
No adverse event
Item
Mark with an X if there are none
boolean
C1963761 (UMLS CUI [1])
MedDRA
Item
MedDRA
text
C1140263 (UMLS CUI [1])
CL Item
Rash/desquamation (1)
C1559142 (UMLS CUI-1)
CL Item
Pruritus (2)
C0033774 (UMLS CUI-1)
CL Item
Erythema multiforme (3)
C0014742 (UMLS CUI-1)
CL Item
Nail changes (4)
C0234909 (UMLS CUI-1)
CL Item
Dry skin (5)
C0151908 (UMLS CUI-1)
CL Item
Other, specify (6)
C3845569 (UMLS CUI-1)
Other,specify
Item
Other, specify
text
C3845569 (UMLS CUI [1])
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
Item
Cetuximab Dose Modification
integer
C0995188 (UMLS CUI [1,1])
C1707811 (UMLS CUI [1,2])
C1707811 (UMLS CUI [1,2])
CL Item
Dose held (1)
C0178602 (UMLS CUI-1)
C0549178 (UMLS CUI-2)
C0549178 (UMLS CUI-2)
CL Item
Dose reduced (2)
C1707814 (UMLS CUI-1)
CL Item
Drug discontinued (3)
C0558681 (UMLS CUI-1)
Adverse event onset date
Item
Adverse event onset date
date
C2985916 (UMLS CUI [1])
Adverse event end date
Item
Adverse event end date
date
C2697886 (UMLS CUI [1])
Adverse event ongoing
Item
If ongoing mark with an X
boolean
C2826663 (UMLS CUI [1])
Completed by
Item
Completed by
text
C1550483 (UMLS CUI [1])
Date form originally completed
Item
Date form originally completed
date
C1549507 (UMLS CUI [1])